内源性皮质醇增多症诊断的临床与生化数据:「Cushingomic」方法
该研究纳入615例无库欣综合征(CS)患者(263例疑似CS、319例肾上腺偶发瘤、33例垂体偶发瘤)和40例CS患者,分析筛查试验的诊断准确性。结果显示1-mg过夜地塞米松抑制试验(DST)和尿游离皮质醇(UFC)略优于深夜唾液皮质醇(LNSC);肾上腺偶发瘤(AI)伴轻度自主皮质醇分泌时DST切点应提高至196 nmol/L。结合筛查试验与临床表现的神经网络模型在验证队列中预测CS的精确度为99%、准确度为86%。
要点
- 1-mg过夜DST和UFC对CS的诊断准确性略优于LNSC。
- AI伴轻度自主皮质醇分泌时,DST鉴别CS的切点应提高至196 nmol/L。
- 结合筛查试验与临床表现的神经网络模型在验证队列中精确度99%、准确度86%。
核心结论
- 尽管筛查试验检测CS的诊断准确性高,但解读阳性结果时应考虑皮质醇相关合并症或AI。
研究设计与样本
- 研究纳入615例无CS患者(263例疑似CS、319例肾上腺偶发瘤、33例垂体偶发瘤)和40例CS患者,采用主成分分析、K-means聚类和神经网络对筛查试验、合并症及高皮质醇血症体征/症状进行整合分析。
主要发现
- 筛查试验对CS的诊断准确性高;DST和UFC略优于LNSC。
- 糖尿病、高血压和肥胖在无CS患者中更常见:其向量方向不一致,且与筛查试验的相关性差。
- 聚类分析将无CS患者分为聚类1(老年骨质疏松患者伴筛查试验异常)、聚类2(高血压和代谢表型)和聚类3(年轻且显性CS可能性低的个体)。
- 结合筛查试验和临床表现的神经网络模型在验证队列中预测CS诊断的精确度为99%、准确度为86%。
关键数值与推荐
- DST阈值应适应所考虑的人群,尤其是肾上腺偶发瘤(AI)伴轻度自主皮质醇分泌:鉴别CS的切点应提高至196 nmol/L。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: The clinical presentation of Cushing syndrome (CS) overlaps with common conditions. Recommended screening tests are serum cortisol after 1-mg overnight dexamethasone suppression test (DST), urinary free cortisol (UFC), and late-night salivary cortisol (LNSC). OBJECTIVE: We analyzed the diagnostic accuracy of screening tests in 615 patients without CS (263 suspected CS, 319 adrenal and 33 pituitary incidentaloma) and 40 with CS. METHODS: Principal component analysis, K-means clustering, and neural network were used to compute an integrated analysis among tests, comorbidities, and signs/symptoms of hypercortisolism. RESULTS: The diagnostic accuracy of screening tests for CS was high; DST and UFC were slightly superior to LNSC. The threshold of DST should be adapted to the population considered, especially in adrenal incidentaloma (AI) with mild autonomous cortisol secretion: The cutoff to differentiate CS should be increased to 196 nmol/L. Diabetes, hypertension, and obesity were more common in patients without CS: The direction of their vectors was not aligned and their correlation with screening tests was poor. Clustering allowed us to differentiate those patients without CS into cluster 1 (aged osteoporotic patients with impaired screening tests), cluster 2 (hypertensive and metabolic phenotype), and cluster 3 (young individuals with a low likelihood of overt CS). A neural network model that combined screening tests and clinical presentation was able to predict the CS diagnosis in the validation cohort with 99% precision and 86% accuracy. CONCLUSION: Despite the high diagnostic accuracy of screening tests to detect CS, cortisol-related comorbidities or AI should be considered when interpreting a positive test.
引用
- Ceccato F, Bavaresco A, Ragazzi E, et al. Clinical and Biochemical Data for the Diagnosis of Endogenous Hypercortisolism: The "Cushingomic" Approach. J Clin Endocrinol Metab. 2025. PMID: 39056252. doi:10.1210/clinem/dgae517
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。